[Access of developing countries to essential drugs: a process of equity].
In the context of the fight against poverty, the access of developing countries to essential drugs mobilizes the international community. It leads to envisage new and intricates politics. If donations or tiered prices are studied, the manufacturing of generics and even of patented drugs through voluntary or compulsory licensing is evoked. At a longer terms, it's the setting of health national politics and industrialisation which are concerned. These new orientations are not without consequence on the global drug market.
Campion
M D
MD
L'Université Droit et Santé de Lille II, Faculté des Sciences pharmaceutiques et biologiques, 3 rue du professeur Laguesse, BP 83, 59006 Lille.
D003906:Developing Countries; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence; D018954:Drugs, Essential / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics*; D006801:Humans; D007391:International Cooperation; D011057:Politics; D011203:Poverty
D018954:Drugs, Essential; D016568:Drugs, Generic